A: Summary Missing Count,total_attributes,publisher,C: Coverage & Detail Total Attributes,missing_attributes,title,A: Summary Total Attributes,F: Technical Metadata Missing Count,B: Business Total Attributes,D: Format & Structure Missing Count,E: Attribution Total Attributes,F: Technical Metadata Total Attributes,C: Coverage & Detail Missing Count,E: Attribution Missing Count,id,B: Business Missing Count,D: Format & Structure Total Attributes
0,42,ALLIANCE > NIHR BIORESOURCE,10,29,Metabolite data,7,7,9,4,3,7,8,3,004d1932-f06e-49d2-b87a-e5e4140ffbb3,8,5
0,42,ALLIANCE > HQIP,10,29,National Joint Registry - Primary Elbow Replacement dataset,7,7,9,4,3,7,8,3,0092dc60-a0af-4d45-801c-b888210d6609,8,5
0,42,ALLIANCE > DUNDEE,10,33,Tayside Pathology,7,7,9,5,3,7,10,3,014bc853-1b27-4d97-9e5e-97fe28b84769,9,5
0,42,ALLIANCE > SCOTLAND,10,16,Scotland Accident and Emergency,7,6,9,4,3,7,2,2,01728d51-19eb-4527-8add-6b660cb557cc,2,5
0,42,ALLIANCE > HQIP,10,29,Paediatric Intensive Care Audit Network - core dataset (admission),7,7,9,4,3,7,8,3,0217114b-6847-4aae-9d76-4d52acea2bcc,8,5
0,42,ALLIANCE > CPRD,10,17,HES Diagnostic Imaging Dataset for CPRD Aurum,7,6,9,3,3,7,3,2,0266f904-b168-488a-a9e7-d318443584ef,3,5
0,42,Oxford University Hospitals NHS Foundation Trust,10,33,SOLUS,7,7,9,5,3,7,10,3,0477b06f-cbed-4949-982e-ce248a47ed1a,9,5
0,42,ALLIANCE > HQIP,10,29,National Cardiac Audit Programme - Myocardial Ischaemia National Audit Project (MINAP),7,7,9,4,3,7,8,3,04b1648d-eeb7-4072-8dd2-806c3ae4e20d,8,5
0,42,ALLIANCE > BARTS,10,33,Sectra PACS,7,7,9,5,3,7,10,3,04f4604e-6d0b-4100-977b-59c3b69b0cfc,9,5
0,42,ALLIANCE > TISSUE DIRECTORY,10,11,Infectious Diseases BioBank at King's College London,7,7,9,2,3,7,2,0,0534b41b-9877-4e30-b3ce-e604b29d4990,1,5
0,42,ALLIANCE > LEICESTER,10,29,The Primary-Secondary Care Partnership to Improve Outcomes in Chronic Kidney Disease,7,7,9,4,3,7,8,3,05ade19c-75f5-4623-ade6-99fb21c2d4e3,8,5
0,42,Oxford University Hospitals NHS Foundation Trust,10,33,Millennium Clinical Events,7,7,9,5,3,7,10,3,0711cc7e-80d5-4781-a1ab-2637ea176ceb,9,5
0,42,ALLIANCE > NIHR BIORESOURCE,10,33,Returned datasets,7,7,9,5,3,7,10,3,07abf678-a2c0-4d8b-8d25-8b9f180f9ff2,9,5
0,42,ALLIANCE > HQIP,10,29,Paediatric Intensive Care Audit Network - customised data collection,7,7,9,4,3,7,8,3,09586db0-4da4-47f8-9434-13cbd2da2bb9,8,5
0,42,HUBS > BREATHE,10,8,Idiopathic Pulmonary Fibrosis (IPF) Genome-wide Association Study,7,7,9,0,3,7,0,0,0a0b0779-2d76-461d-9621-be54c3a3e98a,2,5
0,42,ALLIANCE > HQIP,10,29,Paediatric Intensive Care Audit Network - core dataset (transport),7,7,9,4,3,7,8,3,0a418d30-c13c-404a-9f4c-39334d889b9c,8,5
0,42,ALLIANCE > TISSUE DIRECTORY,10,11,Tayside Biorepository,7,7,9,2,3,7,2,0,0a4f19cc-8565-410b-ac02-2751f5284a9b,1,5
0,42,HUBS > DISCOVER NOW,10,7,North West London Accident and Emergency Data (NWL A&E),7,6,9,0,3,7,1,0,0a524760-0efc-477e-8a3b-805e1a0f67ec,0,5
0,42,ALLIANCE > HQIP,10,29,National Asthma and COPD Audit Programme (NACAP): Pulmonary rehabilitation - clinical audit,7,7,9,4,3,7,8,3,0bb202c7-80e8-4532-8042-1351576e6c94,8,5
0,42,NHS Digital,10,20,Mental Health Services Data Set - Community,7,7,9,5,3,7,5,3,0c98200b-48b5-418a-b8d0-a7708abc1f39,1,5
0,42,ALLIANCE > BARTS,10,33,ARIA Dataset,7,7,9,5,3,7,10,3,0cfe60cd-038d-4c03-9a95-894c52135922,9,5
0,42,ALLIANCE > HQIP,10,29,National Neonatal Audit Programme - clinical audit,7,7,9,4,3,7,8,3,0d89c503-1c79-4e2a-baf6-02f12e68805b,8,5
0,42,ALLIANCE > TISSUE DIRECTORY,10,10,IMPORT HIGH trial blood samples,7,7,9,2,3,7,2,0,0df3a0a9-d261-47ff-99e5-9c7e67410712,0,5
0,42,ALLIANCE > CPRD,10,16,HES Accident and Emergency data for CPRD Aurum,7,6,9,2,3,7,3,2,0e59698c-1532-4155-ab0e-af11b3d9e7b1,3,5
0,42,NHS Digital,10,19,Mental Health Minimum Dataset v4 (Sensitive) Episodes,7,6,9,5,3,7,4,3,0e6e6ed5-ab81-4d7f-b06a-768bf33357ca,1,5
0,42,ALLIANCE > SAIL,10,6,National Community Child Health Database (NCCHD),7,6,9,0,3,7,0,0,0e88bc9d-bdfb-417c-8926-fdc513f5e8da,0,5
0,42,ALLIANCE > CPRD,10,26,National Radiotherapy Dataset (RTDS) for CPRD Aurum,7,6,9,5,3,7,8,3,0fbd11c2-c44b-430f-b527-63cb82fcee63,4,5
0,42,NHS Digital,10,19,Mental Health & Learning Disabilities Dataset v 1 (Non-Sensitive) Events,7,6,9,5,3,7,4,3,0fc61ace-397d-4489-9e62-77f88082e775,1,5
0,42,ALLIANCE > DUNDEE,10,33,Tayside & Fife Diabetes â€“ Summary and a range of diabetes related datasets.,7,7,9,5,3,7,10,3,0ff88499-931b-4614-9f81-facf21f28174,9,5
0,42,ALLIANCE > HQIP,10,29,National Audit of Dementia Round 4 - carer experience survey,7,7,9,4,3,7,8,3,11571357-b9fc-45ed-ab40-3bb3d7443245,8,5
0,42,HUBS > NHS DIGITRIALS,10,19,Hospital Episode Statistics Critical Care,7,6,9,5,3,7,4,3,11a60dee-d14a-447a-9e59-0bbc109919d2,1,5
0,42,ALLIANCE > HQIP,10,29,National Vascular Registry Audit Carotid Lower Limb Amputation clinical dataset,7,7,9,4,3,7,8,3,12690263-f5d3-435b-9582-de1a88064e1e,8,5
0,42,ALLIANCE > HQIP,10,29,National Joint Registry - Revision Hip Replacement dataset,7,7,9,4,3,7,8,3,12c5b83c-6e4a-442e-b6c2-2f6b7165fe6b,8,5
0,42,ALLIANCE > TISSUE DIRECTORY,10,11,Obesity Research Biobank Syndicate (ORBiS),7,7,9,2,3,7,2,0,13a931c1-18cf-4d60-be79-a527acb0a36d,1,5
0,42,ALLIANCE > TISSUE DIRECTORY,10,11,Watch and Wait Trial,7,7,9,2,3,7,2,0,14855eb1-6563-4e56-89e5-aecd51f100ad,1,5
0,42,ALLIANCE > HQIP,10,29,Paediatric Intensive Care Audit Network - core dataset (referral),7,7,9,4,3,7,8,3,148a3896-e4ed-48ef-8643-48df726041e1,8,5
0,42,ALLIANCE > SAIL,10,9,Annual District Death Daily,7,6,9,2,3,7,1,0,14a752a8-8efa-4bab-85c1-190e1f20c8cf,0,5
0,42,ALLIANCE > GENOMICS ENGLAND,10,6,GENOMICS ENGLAND 100K NHSD LINKED DATA,7,6,9,0,3,7,0,0,15a7c12f-145c-46fc-acc9-c27e83ed2c4d,0,5
0,42,ALLIANCE > TISSUE DIRECTORY,10,11,INCA Trial,7,7,9,2,3,7,2,0,16341d43-0e79-4afa-a84f-67db018e449f,1,5
0,42,ALLIANCE > SAIL,10,7,Pathology Data from WRRS,7,6,9,0,3,7,0,1,16dfba9a-04b9-4b3e-9c86-73d6bf2db4c3,0,5
0,42,Oxford University Hospitals NHS Foundation Trust,10,33,ARIA Medonc,7,7,9,5,3,7,10,3,172242ce-a1c5-4915-9c71-686f6e7d5789,9,5
0,42,ALLIANCE > TISSUE DIRECTORY,10,10,IDRIS Trial,7,7,9,2,3,7,2,0,179c21cd-41e0-489b-82c4-1bec011c562f,0,5
0,42,ALLIANCE > CPRD,10,25,Rural-Urban classification for CPRD GOLD,7,6,9,5,3,7,8,3,1841e7c9-39e1-4eff-9d2f-da3dede71f86,3,5
0,42,ALLIANCE > HQIP,10,29,National Audit of Psychosis - Audit on Early Intervention in Psychosis services - case note audit,7,7,9,4,3,7,8,3,18603ae7-a056-4fd6-a3e5-d32a2440dd26,8,5
0,42,ALLIANCE > SCOTLAND,10,17,Child Health Systems Programme - 13-15 Month Review,7,7,9,4,3,7,2,2,187ad2a0-429b-4047-b399-109a37acef25,3,5
0,42,ALLIANCE > HQIP,10,29,National Asthma and COPD Audit Programme (NACAP): COPD secondary care clinical dataset,7,7,9,4,3,7,8,3,1a0af437-ec80-4db7-9c76-a2418cc8c5c8,8,5
0,42,ALLIANCE > SCOTLAND,10,17,Scottish Birth Record (SBR),7,7,9,4,3,7,2,2,1a575fae-c0d7-4718-b0d6-ba7c9c3edc0d,3,5
0,42,ALLIANCE > DUNDEE,10,33,NHS Tayside and Fife Accident & Emergency Dataset (ISD/National),7,7,9,5,3,7,10,3,1aa60c9f-a458-454d-802a-e4c4628f3870,9,5
0,42,ALLIANCE > TISSUE DIRECTORY,10,10,DARWIN1 Trial,7,7,9,2,3,7,2,0,1bb2c353-8d91-4989-a21b-26182262b807,0,5
0,42,ALLIANCE > TISSUE DIRECTORY,10,11,NICAM: Nilotinib treatment for c-KIT mutated advanced AMM,7,7,9,2,3,7,2,0,1c17f45b-ba0f-4e97-a0f0-34a600844d4f,1,5
0,42,ALLIANCE > TISSUE DIRECTORY,10,11,HPB Biobank,7,7,9,2,3,7,2,0,1cb31e11-505b-4ff6-ae20-5c468c9ad296,1,5
0,42,HUBS > PIONEER,10,29,University Hospitals Birmingham PICS data,7,7,9,4,3,7,8,3,1d1244b6-aeeb-4655-b5a2-2357ed28227a,8,5
0,42,ALLIANCE > TISSUE DIRECTORY,10,11,National Diet and Nutrition Survey (NDNS),7,7,9,2,3,7,2,0,1d2a94c4-b18d-47c4-9b48-cfab8e67f126,1,5
0,42,NHS Digital,10,20,Mental Health Services Data Set - Service Users,7,7,9,5,3,7,5,3,1d5e3b05-8ce3-4f80-ae3a-f6031ad8cf69,1,5
0,42,HUBS > BREATHE,10,8,UK BiLEVE Consortium Dataset,7,7,9,0,3,7,0,0,1d7d2724-3175-438b-a3a3-77875f776548,2,5
0,42,ALLIANCE > HQIP,10,29,National Cardiac Audit Programme - National Audit of Percutaneous Coronary Interventions (PCI),7,7,9,4,3,7,8,3,1da704e3-f5ee-4614-8880-10541637a0b7,8,5
0,42,HUBS > BREATHE,10,15,COPDMAP Consortium,7,7,9,1,3,7,5,0,1e266f05-4fa8-40d8-a008-7dff627bfa9b,3,5
0,42,ALLIANCE > TISSUE DIRECTORY,10,11,University of Southampton Faculty of Medicine Tissue Bank,7,7,9,2,3,7,2,0,201602df-7432-4710-98a7-18f59e4f211e,1,5
0,42,ALLIANCE > TISSUE DIRECTORY,10,9,RIO,7,7,9,0,3,7,2,0,209f42a8-4581-49e1-a0c2-25069a37f230,1,5
0,42,ALLIANCE > TISSUE DIRECTORY,10,11,TNT: Triple Negative breast cancer Trial,7,7,9,2,3,7,2,0,20c2a274-843c-43fa-9b76-38ef2f8a3d64,1,5
0,42,SLaM,10,6,South London and Maudsley NHS Foundation Trust (SLaM) Clinical Record Interactive Search (CRIS) platform,7,7,9,0,3,7,0,0,21cd4b8e-f4f5-44a6-83eb-b7799e98ba55,0,5
0,42,HUBS > DISCOVER NOW,10,7,North West London Mental Health Data (NWL MH),7,6,9,0,3,7,1,0,21d58202-15a2-4ec8-9f36-3080de3905a5,0,5
0,42,ALLIANCE > SCOTLAND,10,17,Child Health Systems Programme - 6-8week review,7,6,9,4,3,7,2,2,22277cb3-effc-4422-84aa-de1e31ee5442,3,5
0,42,Barts Health NHS Trust,10,33,Emergency Care Dataset (ECDS),7,7,9,5,3,7,10,3,226fb3f1-4471-400a-8c39-2b66d46a39b6,9,5
0,42,HUBS > DISCOVER NOW,10,7,North West London Pathology (NWL PATH),7,6,9,0,3,7,1,0,22a99111-46ad-4d3f-a2d5-09351e851350,0,5
0,42,ALLIANCE > HQIP,10,29,National Joint Registry - Revision Knee Replacement dataset,7,7,9,4,3,7,8,3,23330792-fe18-4331-a101-b246657a03ae,8,5
0,42,ALLIANCE > TISSUE DIRECTORY,10,11,Human Biomaterials Resource Centre,7,7,9,2,3,7,2,0,236108a2-5e2c-4acb-86e7-6ec793aef8ab,1,5
0,42,ALLIANCE > HQIP,10,29,Falls and Fragility Fracture Audit Programme Fracture Liaison Service Database clinical dataset,7,7,9,4,3,7,8,3,237e724d-03b2-478c-a92d-85a1baa6ae53,8,5
0,42,NHS Digital,10,19,Mental Health Minimum Dataset v4 (Non-Sensitive) Episodes,7,6,9,5,3,7,4,3,263ad0a8-ae90-4c1d-85d6-c3d2470eb2b7,1,5
0,42,NHS Digital,10,19,Mental Health Minimum Dataset v2.6 (Sensitive),7,6,9,5,3,7,4,3,263f28a4-9835-4856-b1c3-0a0d4085f207,1,5
0,42,ALLIANCE > BARTS,10,32,CDE Patient Demographics,7,7,9,5,3,7,9,3,2684706f-1d43-4263-99b7-b54279614c76,9,5
0,42,ALLIANCE > SCOTLAND,10,14,General Acute Inpatient and Day Case - Scottish Morbidity Record (SMR01),7,7,9,1,3,7,2,2,26f8bf57-e074-41d0-80aa-67a677604607,3,5
0,42,ALLIANCE > HQIP,10,29,National Asthma and COPD Audit Programme (NACAP): secondary care workstream â€“ children and young people asthma (clinical),7,7,9,4,3,7,8,3,278c3fb2-6b1e-46db-a529-9fc7ddaf4461,8,5
0,42,ALLIANCE > SCOTLAND,10,14,Mental Health Inpatient and Day Case - Scottish Morbidity Record (SMR04),7,7,9,1,3,7,2,2,28376eb7-654f-4076-81c6-743d89d4e712,3,5
0,42,ALLIANCE > TISSUE DIRECTORY,10,11,IoN Trial,7,7,9,2,3,7,2,0,2a5d2a42-803c-4c96-bcd6-a4289d2b664a,1,5
0,42,NHS Digital,10,19,Mental Health & Learning Disabilities Dataset v 1 (Sensitive) Records,7,6,9,5,3,7,4,3,2a725f9d-c4a9-4c89-aa37-b3c25cc83389,1,5
0,42,ALLIANCE > TISSUE DIRECTORY,10,11,ESPAC-TPlus,7,7,9,2,3,7,2,0,2aa58bb8-83d8-455a-87e6-d567ae4a379c,1,5
0,42,ALLIANCE > TISSUE DIRECTORY,10,11,NIHR Nottingham Digestive Diseases Collection,7,7,9,2,3,7,2,0,2b198886-ccab-4276-b6b9-22c344df8304,1,5
0,42,ALLIANCE > TISSUE DIRECTORY,10,10,BRAIN UK,7,7,9,2,3,7,2,0,2bf53952-e77c-4746-b36f-5ccb1574f6a7,0,5
0,42,ALLIANCE > HQIP,10,29,National Joint Registry - Revision Ankle Replacement dataset,7,7,9,4,3,7,8,3,2c0e04bc-2f16-4903-90dc-c9d57ab40efb,8,5
0,42,ALLIANCE > HQIP,10,29,National Diabetes Inpatient Audit Hospital Characteristics Survey dataset,7,7,9,4,3,7,8,3,2c53d1f7-4540-4c57-8e93-8115b8abc6a9,8,5
0,42,ALLIANCE > CPRD,10,25,Rural-Urban classification for CPRD Aurum,7,6,9,5,3,7,8,3,2d23ad3c-0541-453c-8bf7-9dc42e1aba65,3,5
0,42,ALLIANCE > CPRD,10,25,Quality of Life of Cancer Survivors in England: Pilot Patient Reported Outcomes Measures Survey (2011) for CPRD Aurum,7,6,9,5,3,7,8,3,2d3302d1-b6fc-4883-8168-010da0d48638,3,5
0,42,ALLIANCE > CYSTIC FIBROSIS,10,8,Liver Enzyme,7,6,9,1,3,7,1,0,2d3d2c36-240e-4d38-a6ae-893bafbf6fbb,0,5
0,42,ALLIANCE > HQIP,10,29,Falls and Fragility Fracture Audit Programme National Hip Database Facilities Survey 2019,7,7,9,4,3,7,8,3,2dbd2e38-a4bb-4f8c-b401-ebec10f0d89e,8,5
0,42,ALLIANCE > SAIL,10,8,Outpatient Dataset,7,6,9,0,3,7,1,1,2e0d71a2-3d09-4cf4-beb3-df3ec1b1f240,0,5
0,42,ALLIANCE > TISSUE DIRECTORY,10,10,NHS Greater Glasgow & Clyde Bio-Repository,7,7,9,2,3,7,2,0,2e20b776-a0bc-44ed-9882-ad63855a0ec4,0,5
0,42,ALLIANCE > CPRD,10,25,Mental Health Dataset (MHDS) for CPRD Aurum,7,6,9,5,3,7,8,3,2e8cc70b-bd57-4b64-bd12-fbc07e0f240f,3,5
0,42,"HUBS > GUT REACTION, ALLIANCE > NIHR BIORESOURCE",10,10,Contact detail,7,6,9,1,3,7,2,0,2e986f12-6195-4cb8-ab71-80f4a60619e6,1,5
0,42,ALLIANCE > TISSUE DIRECTORY,10,11,BioDock,7,7,9,2,3,7,2,0,2f57c592-c65c-4d1c-b92d-d19d2a11c02e,1,5
0,42,ALLIANCE > HQIP,10,29,National Audit of Dementia Round 4 - casenote audit,7,7,9,4,3,7,8,3,304430ff-0aff-4d36-91e5-94be251a409a,8,5
0,42,ALLIANCE > TISSUE DIRECTORY,10,10,PHOTO Translational bladder cancer biorepository,7,7,9,2,3,7,2,0,319a2a77-3f4d-497e-bc3e-33002f316cae,0,5
0,42,ALLIANCE > TISSUE DIRECTORY,10,11,LBIH Biobank,7,7,9,2,3,7,2,0,32b5d90f-6bad-40f8-96d7-69b11df6d5ff,1,5
0,42,ALLIANCE > TISSUE DIRECTORY,10,8,Scottish Human Papillomavirus Archive,7,7,9,0,3,7,2,0,342bef6e-8fa2-49f0-bdbb-c95d866aa145,0,5
0,42,ALLIANCE > TISSUE DIRECTORY,10,11,Human Developmental Biology Resource (HDBR),7,7,9,2,3,7,2,0,355de4ca-1ce9-4ba4-8e07-2d51bb82bfbf,1,5
0,42,NHS Digital,10,19,Mental Health Minimum Dataset v3_3.5 (Sensitive),7,6,9,5,3,7,4,3,36047c5f-7d57-4d25-a114-2bcc6c11708f,1,5
0,42,ALLIANCE > TISSUE DIRECTORY,10,11,NIMRAD-TRANS,7,7,9,2,3,7,2,0,3784d68e-d213-43a7-bf30-8f4d34de022c,1,5
0,42,ALLIANCE > TISSUE DIRECTORY,10,11,"Leeds Dental Institute/School of Dentistry Leeds, Skeletal Tissues Bank",7,7,9,2,3,7,2,0,37fe2488-f4c3-4471-a1e0-7d4a4204f063,1,5
0,42,HUBS > DATA-CAN,10,8,Childrenâ€™s Kidney Cancers - Great Ormond Street Hospital,7,6,9,0,3,7,2,0,38b7cb24-d401-4f7e-b4ff-ddfd9329ac40,0,5
0,42,HUBS > DISCOVER NOW,10,7,North West London High Cost Drugs Data (NWL HCD),7,6,9,0,3,7,1,0,3932ee85-69cb-414a-b4a0-b763010d90a5,0,5
0,42,NHS Digital,10,19,Bridge file: Hospital Episode Statistics to Diagnostic Imaging Dataset,7,6,9,5,3,7,4,3,3935e2fd-0c30-4f56-8388-45a02e0499b4,1,5
0,42,ALLIANCE > CPRD,10,26,National Radiotherapy Dataset (RTDS) for CPRD GOLD,7,6,9,5,3,7,8,3,3943e6de-6c32-43dd-8090-16ec9ca0902f,4,5
0,42,ALLIANCE > HQIP,10,29,National Cardiac Audit Programme - Cardiac Rhythm Management (CRM),7,7,9,4,3,7,8,3,395262e7-9846-4d9d-a288-8b0ebea782b9,8,5
0,42,ALLIANCE > TISSUE DIRECTORY,10,10,The Cleft Collective,7,7,9,2,3,7,2,0,3983f3ec-ce63-4142-b73e-93130654710b,0,5
0,42,ALLIANCE > TISSUE DIRECTORY,10,10,PHOENIX DDR-Anti-PD-L1 Trial,7,7,9,2,3,7,2,0,3a0599ed-5452-4299-956c-af5a30bbef23,0,5
0,42,ALLIANCE > TISSUE DIRECTORY,10,11,SWIFT-RTB,7,7,9,2,3,7,2,0,3a23e7dc-d814-4772-a6f8-a814c8e0128b,1,5
0,42,ALLIANCE > HQIP,10,29,Epilepsy 12 - clinical audit,7,7,9,4,3,7,8,3,3a51b861-026d-45ed-abe6-30d9cc07b516,8,5
0,42,ALLIANCE > HQIP,10,29,National Paediatric Diabetes Audit - Spotlight survey of workforce in Paediatric Diabetes Units,7,7,9,4,3,7,8,3,3a9ab245-5fcc-49a0-ae58-12ebab9b0053,8,5
0,42,ALLIANCE > CYSTIC FIBROSIS,10,8,Demographics,7,6,9,1,3,7,1,0,3b4e8fed-1c14-4c79-a20c-dfeab520be89,0,5
0,42,ALLIANCE > SCOTLAND,10,17,Scottish Immunisation Recall System (SIRS),7,7,9,4,3,7,2,2,3b930e97-b8eb-4680-9ad1-db6bccc6e1d8,3,5
0,42,ALLIANCE > BARTS,10,33,"Problems, Diagnosis and Procedures",7,7,9,5,3,7,10,3,3cd53c68-7e56-4c3e-b7c2-bd7e18040ec5,9,5
0,42,ALLIANCE > DUNDEE,10,33,Renal Register â€“ ISD National dataset,7,7,9,5,3,7,10,3,3d42b7e1-89b0-4bef-9e42-18edc328f28f,9,5
0,42,ALLIANCE > HQIP,10,29,National Clinical Audit of Anxiety and Depression - spotlight audit on psychological therapies (patient experience survey),7,7,9,4,3,7,8,3,3e89692b-7aa2-49d6-b802-82921bd7e006,8,5
0,42,HUBS > BREATHE,10,6,"Extended Cohort for E-health, Environment and DNA (EXCEED)",7,6,9,0,3,7,0,0,3ee52adc-b97e-4f7b-a251-a1c9841a380c,0,5
0,42,"HUBS > GUT REACTION, ALLIANCE > NIHR BIORESOURCE",10,11,Consent records,7,6,9,2,3,7,2,0,3f1e8d9c-df81-4374-815c-621ab3013581,1,5
0,42,ALLIANCE > HQIP,10,29,National Emergency Laparotomy Audit - Patient Audit Dataset,7,7,9,4,3,7,8,3,3f299029-3126-4ce0-893c-4a759cbe90b1,8,5
0,42,ALLIANCE > DUNDEE,10,33,Walker Study Data,7,7,9,5,3,7,10,3,3fd5f728-fdb4-4ce2-86ec-f626787d455c,9,5
0,42,Oxford University Hospitals NHS Foundation Trust,10,33,Endobase,7,7,9,5,3,7,10,3,40573895-497b-4d47-90e1-6aafe70b93f6,9,5
0,42,ALLIANCE > TISSUE DIRECTORY,10,10,Bloodwise Childhood Leukaemia Cell Bank,7,7,9,2,3,7,2,0,406e7ae7-554b-4807-b3a5-a4d81316cf9c,0,5
0,42,HUBS > DISCOVER NOW,10,7,North West London Outpatient Care Data (NWL OP),7,6,9,0,3,7,1,0,41a7adba-8771-46e2-8083-047d6a4cb877,0,5
0,42,ALLIANCE > CYSTIC FIBROSIS,10,7,Transplants,7,6,9,0,3,7,1,0,425de2a1-5216-4973-a5cd-5cd3c35e40b3,0,5
0,42,NHS Digital,10,20,Mental Health and Learning Disabilities Data Set,7,6,9,5,3,7,5,3,4262e057-6978-4e4c-a05d-c4f328422090,1,5
0,42,ALLIANCE > HQIP,10,29,National Neonatal Audit Programme - 2 year outcomes audit,7,7,9,4,3,7,8,3,4271bc64-b139-40b0-98de-5f2e94e2d026,8,5
0,42,ALLIANCE > CPRD,10,20,HES Patient Reported Outcomes Measures (PROMs) data for CPRD Aurum,7,6,9,3,3,7,5,3,42780b16-32e3-442e-92cd-1810bf30dab8,3,5
0,42,ALLIANCE > HQIP,10,29,Falls and Fragility Fracture Audit Programme National Audit of Inpatient Falls clinical dataset,7,7,9,4,3,7,8,3,430331ef-fa66-485b-b090-e4e83def9136,8,5
0,42,HUBS > INSIGHT,10,14,PIONNER - Genomics Patients and related data,7,7,9,4,3,7,4,0,44ebf07b-48aa-49c6-b45a-6aecf389fdb2,0,5
0,42,NHS Digital,10,19,Mental Health Minimum Dataset v4 (Sensitive) Events,7,6,9,5,3,7,4,3,46493a09-b3bb-4c0e-b944-82665ee21508,1,5
0,42,ALLIANCE > DUNDEE,10,33,Deaths General Registrar Office â€“ National Records Scotland,7,7,9,5,3,7,10,3,464b06d6-239a-4c6d-a626-242ba7e79e05,9,5
0,42,ALLIANCE > HQIP,10,29,National Vascular Registry - Organisational Audit dataset,7,7,9,4,3,7,8,3,4678a81d-dfb6-478a-a373-d5510866b3d0,8,5
0,42,ALLIANCE > HQIP,10,29,National Cardiac Audit Programme - National Congenital Heart Disease Audit (NCHDA),7,7,9,4,3,7,8,3,46e4c3ba-dae2-453d-832a-88ea603110f1,8,5
0,42,ALLIANCE > SAIL,10,7,COVID-19 Test results,7,6,9,0,3,7,1,0,479ff1c9-444c-4855-a65d-ddc37f040120,0,5
0,42,ALLIANCE > HQIP,10,29,National Vascular Registry Audit - Lower Limb Bypass clinical dataset,7,7,9,4,3,7,8,3,47bec08b-57b7-450e-9be7-af19bab99b58,8,5
0,42,ALLIANCE > CYSTIC FIBROSIS,10,7,CFQ-R,7,6,9,0,3,7,1,0,48e1ee09-4dcb-40ce-8236-b64ce7f92aad,0,5
0,42,ALLIANCE > DUNDEE,10,33,Tayside Microbiology: Isolations,7,7,9,5,3,7,10,3,4a295c54-ccbb-4aef-9ea9-8fc46749b123,9,5
0,42,HUBS > NHS DIGITRIALS,10,19,Hospital Episode Statistics Accident and Emergency,7,6,9,5,3,7,4,3,4aaf4b66-1bd3-4213-9c86-2626ace88740,1,5
0,42,ALLIANCE > HQIP,10,29,National Paediatric Diabetes Audit - Spotlight survey of diabetes-related technologies,7,7,9,4,3,7,8,3,4b71fca4-8b2c-4e37-8996-b64a9c1450f0,8,5
0,42,NHS Digital,10,20,Emergency Care Data Set (ECDS),7,6,9,5,3,7,4,3,4bb4bf38-870b-47e5-b5d1-dc75b3d4ea6a,2,5
0,42,ALLIANCE > TISSUE DIRECTORY,10,11,VinCaP,7,7,9,2,3,7,2,0,4cfabd2a-e590-4f63-82f5-6d543b0075cf,1,5
0,42,ALLIANCE > CYSTIC FIBROSIS,10,8,Microbiology Cultures,7,6,9,1,3,7,1,0,4d6c18fc-54c6-41f1-a7a9-76289c2f4194,0,5
0,42,ALLIANCE > TISSUE DIRECTORY,10,11,Myeloma XII clinical trial samples,7,7,9,2,3,7,2,0,4d95d730-a53a-4856-a278-b2fba96657c4,1,5
0,42,ALLIANCE > HQIP,10,29,National Audit of Psychosis - Audit on Early Intervention in Psychosis services -  patient experience survey,7,7,9,4,3,7,8,3,50631db6-126e-4b3a-8035-444b66ba4afa,8,5
0,42,HUBS > BREATHE,10,6,Prospective Observation of Fibrosis in the Lung Clinical Endpoints,7,7,9,0,3,7,0,0,50feb9f3-3be8-4690-913b-bd462d27d3db,0,5
0,42,Oxford University Hospitals NHS Foundation Trust,10,33,Outpatient Appointment Dataset,7,7,9,5,3,7,10,3,510e1782-1650-4342-9c20-185ca47f7b11,9,5
0,42,ALLIANCE > DUNDEE,10,33,Demography,7,7,9,5,3,7,10,3,514018c0-86e8-4998-8460-bb99912281ae,9,5
0,42,ALLIANCE > CYSTIC FIBROSIS,10,8,Annual Review Encounters,7,6,9,1,3,7,1,0,5261e3d5-b32f-4180-a374-61cab95e63f1,0,5
0,42,HUBS > BREATHE,10,28,International Severe Asthma Registry,7,7,9,5,3,7,7,2,52a4c514-0414-43c7-a400-1498a70ed85a,8,5
0,42,ALLIANCE > SAIL,10,6,Children Receiving Care and Support Census,7,6,9,0,3,7,0,0,5343bac9-244f-4211-8c9a-d9c29c79b4f3,0,5
0,42,ALLIANCE > HQIP,10,29,National Audit of Care at the End of Life - organisational level audit,7,7,9,4,3,7,8,3,535fbfd4-34f0-436d-8de2-e708fd0fa103,8,5
0,42,ALLIANCE > SAIL,10,8,Welsh Cancer Intelligence and Surveillance Unit (WCISU),7,6,9,0,3,7,1,1,54abedcd-d6d8-482b-a3fd-1217101a9a8e,0,5
0,42,ALLIANCE > HQIP,10,29,National Vascular Registry - Lower Limb Angioplasty clinical dataset,7,7,9,4,3,7,8,3,5536b00a-fb31-4e91-9bd8-e7f774974846,8,5
0,42,HUBS > DISCOVER NOW,10,7,North West London population data (NWL POP),7,6,9,0,3,7,1,0,5546a711-109e-440c-815c-1d27a596a625,0,5
0,42,ALLIANCE > SAIL,10,9,Postponed Admitted Procedures,7,6,9,0,3,7,2,1,5547663c-5be2-4dbb-ad21-baf064838fe0,0,5
0,42,ALLIANCE > SCOTLAND,10,15,Prescribing Information System (PIS),7,6,9,4,3,7,2,0,561f0fd2-ced6-4f05-a801-b6338dbc548b,3,5
0,42,HUBS > NHS DIGITRIALS,10,21,MSDS (Maternity Services Data Set),7,6,9,5,3,7,5,3,56f916b0-441f-41df-bfb2-f127aba045f0,2,5
0,42,ALLIANCE > TISSUE DIRECTORY,10,11,Cardiff School of Dentistry Tooth Bank,7,7,9,2,3,7,2,0,5758964b-1161-48ee-97b5-1e414f406978,1,5
0,42,ALLIANCE > TISSUE DIRECTORY,10,11,Cardamon Clinical Trial Samples,7,7,9,2,3,7,2,0,57f5eb44-bd9b-4ec5-b255-fe915ff74ab5,1,5
0,42,ALLIANCE > TISSUE DIRECTORY,10,11,King's Health Partners Cancer Biobank,7,7,9,2,3,7,2,0,593a5263-e2b5-4433-81c1-30b35a520488,1,5
0,42,ALLIANCE > HQIP,10,29,National Clinical Audit of Anxiety and Depression - spotlight audit on psychological therapies (therapist survey),7,7,9,4,3,7,8,3,59bc96f9-69b7-4763-81a8-ec4695b6b55e,8,5
0,42,ALLIANCE > TISSUE DIRECTORY,10,11,MesobanK,7,7,9,2,3,7,2,0,5ad32bfa-8d4b-45cb-aa10-3b0a4bcfd258,1,5
0,42,HUBS > DISCOVER NOW,10,7,North West London Vulnerable Patient List (NWL VPL),7,6,9,0,3,7,1,0,5af81815-6304-4013-be04-702b15eefab1,0,5
0,42,ALLIANCE > SCOTLAND,10,16,Child Health Systems Programme - First Visit,7,7,9,4,3,7,2,1,5b85d641-73dd-4dba-a1a3-b6340227d2ef,3,5
0,42,ALLIANCE > DUNDEE,10,33,"Deaths â€“ CHI, Community Health Index",7,7,9,5,3,7,10,3,5c01bfbe-5bda-4ff9-b565-d18e6e5d57d8,9,5
0,42,ALLIANCE > DUNDEE,10,33,NHS Tayside and Fife Haematology Biochemistry (Lab Data Restructured),7,7,9,5,3,7,10,3,5c56cfb6-46bb-4414-a963-24eafb0949f6,9,5
0,42,ALLIANCE > SAIL,10,6,COVID-19 Symptom Tracker Dataset,7,6,9,0,3,7,0,0,5dc5998d-efa4-490a-9a46-feb6eb27dabe,0,5
0,42,Oxford University Hospitals NHS Foundation Trust,10,33,ARIA Radonc,7,7,9,5,3,7,10,3,5e022f8f-4d07-44bb-a87c-43e31200fe1e,9,5
0,42,NHS Digital,10,19,Mental Health Services Data Set,7,6,9,5,3,7,4,3,5e37caad-4777-4d7e-be17-32220d8fed05,1,5
0,42,ALLIANCE > HQIP,10,29,National Paediatric Diabetes Audit - core clinical dataset (care processes and outcomes),7,7,9,4,3,7,8,3,5ea9c568-b850-4589-bcbb-6ee0cfd322cd,8,5
0,42,ALLIANCE > TISSUE DIRECTORY,10,11,UK CLL Trials Biobank,7,7,9,2,3,7,2,0,5eecebc6-d896-46de-92df-d108bb193b17,1,5
0,42,ALLIANCE > HQIP,10,29,National Maternity and Perinatal Audit Organisational Survey 2019,7,7,9,4,3,7,8,3,600be397-211b-4f65-9f82-e85f4393fb8a,8,5
0,42,HUBS > NHS DIGITRIALS,10,19,Hospital Episode Statistics Admitted Patient Care,7,6,9,5,3,7,4,3,6111c3eb-028c-429e-a78c-6eb9e6b36b66,1,5
0,42,ALLIANCE > HQIP,10,29,National Clinical Audit of Anxiety and Depression - Core audit of practice,7,7,9,4,3,7,8,3,61cf3b8d-5a1b-4241-aaac-89599bf17ab6,8,5
0,42,ALLIANCE > SAIL,10,6,Covid Vulnerable People's list,7,6,9,0,3,7,0,0,61fb7abd-b0d9-4887-b474-57b1f1d0130a,0,5
0,42,ALLIANCE > TISSUE DIRECTORY,10,10,UK real-world lymphoid tissue bank,7,7,9,2,3,7,2,0,62b17ee5-97e3-468e-ba48-e8685ea28461,0,5
0,42,ALLIANCE > TISSUE DIRECTORY,10,10,UKCTOCS Longitudinal Women's Cohort (UKLWC),7,7,9,2,3,7,2,0,62d11868-51d7-4b3a-99eb-da9f5d3797dc,0,5
0,42,ALLIANCE > DUNDEE,10,33,Fife Microbiology: Tests,7,7,9,5,3,7,10,3,63f6d960-da48-4de6-9183-5518f1ce7644,9,5
0,42,ALLIANCE > DUNDEE,10,33,Prescribing,7,7,9,5,3,7,10,3,64640c6f-bc49-419f-bb2c-13c07d94adc9,9,5
0,42,ALLIANCE > HQIP,10,29,National Audit of Dementia Round 4 - organisational checklist,7,7,9,4,3,7,8,3,64a0ba4d-776c-4979-a4b0-1f1fb6b61c85,8,5
0,42,ALLIANCE > DUNDEE,10,33,NHS Tayside and Fife Immunology (Extractable),7,7,9,5,3,7,10,3,660ae034-5631-4fdb-8af5-cf39015c12f8,9,5
0,42,HUBS > BREATHE,10,13,Leicester Respiratory Research Database,7,7,9,0,3,7,5,0,663146dd-0bc3-4d12-95c7-50873a3d45b6,2,5
0,42,ALLIANCE > SAIL,10,6,Active Adult Survey,7,6,9,0,3,7,0,0,66cb4fac-7b2d-4832-8265-6ee58aaad438,0,5
0,42,ALLIANCE > BARTS,10,33,Critical Care Minimum Dataset,7,7,9,5,3,7,10,3,673626f3-bdac-4d32-9bb8-c890b727c0d1,9,5
0,42,ALLIANCE > SAIL,10,6,Critical Care Dataset,7,6,9,0,3,7,0,0,676c2912-c550-4f9b-ba9e-c4e2f9522cdc,0,5
0,42,ALLIANCE > TISSUE DIRECTORY,10,11,Leeds Breast Research Tissue Bank,7,7,9,2,3,7,2,0,6951e949-6aa3-4670-ad05-db8e954b3524,1,5
0,42,HUBS > INSIGHT,10,7,Moorfields Eye Image Dataset Release 001,7,6,9,0,3,7,1,0,6959639d-5bd2-4b53-918e-8f56784b2870,0,5
0,42,ALLIANCE > TISSUE DIRECTORY,10,10,Northern Ireland Biobank (NIB),7,7,9,2,3,7,2,0,6983134e-c920-47db-957b-47e873644eb0,0,5
0,42,ALLIANCE > SCOTLAND,10,17,Scottish Stillbirth and Infant Death Survey,7,7,9,4,3,7,2,2,69df0e1f-e803-45be-a825-81f85e22ab4c,3,5
0,42,ALLIANCE > SAIL,10,6,Looked After Children Wales,7,6,9,0,3,7,0,0,6a513265-38ff-463c-a6a5-4b6ad5753f15,0,5
0,42,ALLIANCE > CPRD,10,26,Systemic Anti-Cancer Treatment (SACT) data for CPRD GOLD,7,6,9,5,3,7,8,3,6a8066c7-a8f4-44a6-9efd-871b19a3689f,4,5
0,42,ALLIANCE > RCGP,10,7,The Royal College of General Practitioners (RCGP) Research and Surveillance Centre (RSC) primary care sentinel network and database,7,6,9,0,3,7,1,0,6b41863d-690e-492e-8034-303d56f12f22,0,5
0,42,ALLIANCE > HQIP,10,29,National Diabetes Audit - National Diabetes Foot Care Audit clinical dataset,7,7,9,4,3,7,8,3,6b53f274-c927-4b8f-bcc3-1d85fabf16ee,8,5
0,42,HUBS > DISCOVER NOW,10,7,North West London Adult Social Care Data (NWL ASC),7,6,9,0,3,7,1,0,6bcb3286-01a0-4332-b84c-35037759d6b1,0,5
0,42,ALLIANCE > CYSTIC FIBROSIS,10,8,Tendon Rupture,7,6,9,1,3,7,1,0,6c6c46a8-b9b5-4137-a329-1e21030b9efb,0,5
0,42,ALLIANCE > DUNDEE,10,33,"NHS Tayside A&E, Diagnosis dataset during A&E visit",7,7,9,5,3,7,10,3,6cb4e624-a971-4d73-949e-bc57353e512b,9,5
0,42,ALLIANCE > HQIP,10,29,National Joint Registry - Revision Elbow Replacement dataset,7,7,9,4,3,7,8,3,6d1b9b23-1197-4857-9b17-9e26cb0633e8,8,5
0,42,ALLIANCE > CPRD,10,16,HES Outpatient data for CPRD Aurum,7,6,9,2,3,7,3,2,6e1d8f50-f718-4964-9c88-2c80cbaa92b5,3,5
0,42,ALLIANCE > TISSUE DIRECTORY,10,11,Ethical Tissue - University of Bradford,7,7,9,2,3,7,2,0,6e535e7c-0ceb-4666-9361-e75e9c4a97ca,1,5
0,42,ALLIANCE > HQIP,10,29,Epilepsy 12 - Patient Reported Experience Measure,7,7,9,4,3,7,8,3,6efbc62f-6ebb-4f18-959b-1ec6fd0cc6fb,8,5
0,42,ALLIANCE > SCOTLAND,10,14,Maternity Inpatient and Day Case - Scottish Morbidity Record (SMR02),7,7,9,1,3,7,2,2,6f04a3eb-b71e-410b-8fec-5742038290a6,3,5
0,42,ALLIANCE > HQIP,10,10,National Joint Registry - Primary Hip Replacement dataset,7,7,9,0,3,7,2,1,7038a67d-34ca-4754-a50f-41aa2849db69,1,5
0,42,Oxford University Hospitals NHS Foundation Trust,10,33,Infoflex Cancer Registry,7,7,9,5,3,7,10,3,72fe91de-b0c0-423a-ad68-bd7067b20ad8,9,5
0,42,NIHR Health Informatics Collaborative Viral Hepatitis Theme,10,6,HIC Hepatitis v2,7,6,9,0,3,7,0,0,73f54071-62bf-48f5-8be1-569208b18ab8,0,5
0,42,ALLIANCE > CPRD,10,11,CPRD GOLD,7,6,9,1,3,7,3,1,756daeaa-6e47-4269-9df5-477c01cdd271,0,5
0,42,ALLIANCE > HQIP,10,29,National Asthma and COPD Audit Programme (NACAP): secondary care workstream â€“ children and young people asthma (organisational),7,7,9,4,3,7,8,3,76ec0282-02e0-4fff-b016-76bc6ffcb784,8,5
0,42,ALLIANCE > CPRD,10,17,HES Admitted Patient Care data for CPRD GOLD,7,6,9,2,3,7,4,2,77b5cf84-d4f2-4418-bafa-73306cf2d2b2,3,5
0,42,ALLIANCE > SCOTLAND,10,16,National Records of Scotland (NRS) - Stillbirth Data,7,7,9,4,3,7,2,1,77d045a2-41f5-4f4c-8054-60630824265f,3,5
0,42,ALLIANCE > HQIP,10,29,National Audit of Psychosis - Early Intervention Psychosis Audit patient experience survey,7,7,9,4,3,7,8,3,78d25670-9d20-4eb7-a79a-f29e53cc981f,8,5
0,42,NHS Digital,10,19,Mental Health Minimum Dataset v4.1 (Sensitive) Episodes,7,6,9,5,3,7,4,3,78fe2e13-7f40-406f-a584-04909d0ce060,1,5
0,42,ALLIANCE > SAIL,10,6,GP dataset - Welsh Primary Care,7,6,9,0,3,7,0,0,7909f8a5-5440-4b9a-843f-cb48cd1f7e08,0,5
0,42,HUBS > BREATHE,10,23,EMEP4UK Pollution,7,7,9,4,3,7,3,2,79116473-bda2-413c-82ad-ba2b86e5076f,8,5
0,42,ALLIANCE > TISSUE DIRECTORY,10,10,Daisy Tumour Bank,7,7,9,2,3,7,2,0,7a0d678a-a341-4643-af33-bfc22f2f4e9c,0,5
0,42,NHS Digital,10,19,Mental Health & Learning Disabilities Dataset v 1 (Non-Sensitive) Records,7,6,9,5,3,7,4,3,7aa02796-787a-42c2-b97e-d008fa77e4b8,1,5
0,42,ALLIANCE > SCOTLAND,10,17,Child Health Systems Programme - School,7,7,9,4,3,7,2,2,7aeeafe6-1c85-4abc-a307-24b70d2e1586,3,5
0,42,ALLIANCE > SAIL,10,9,Cervical Screening Wales,7,6,9,0,3,7,2,1,7bbc1994-b21b-4ff2-bbdc-86d5934fa11f,0,5
0,42,ALLIANCE > TISSUE DIRECTORY,10,11,PTCL Biobank,7,7,9,2,3,7,2,0,7c1fa7b2-2b76-4952-884e-8ef6f845c488,1,5
0,42,ALLIANCE > GENOMICS ENGLAND,10,6,GENOMICS ENGLAND 100K BIOINFORMATICS DATA,7,6,9,0,3,7,0,0,7c9f9620-8f18-4e2d-bda0-a3a6f46756b6,0,5
0,42,ALLIANCE > TISSUE DIRECTORY,10,10,Bristol Dental School Saliva Bank,7,7,9,2,3,7,2,0,7ca98657-037c-43a8-872a-65a0520695e5,0,5
0,42,ALLIANCE > BARTS,10,33,Somerset Cancer Registry,7,7,9,5,3,7,10,3,7d501f79-5d1f-4104-a5b7-d46a97fcde5f,9,5
0,42,ALLIANCE > HQIP,10,29,National Asthma and COPD Audit Programme (NACAP): Adult Asthma secondary care clinical dataset,7,7,9,4,3,7,8,3,7dc319da-a16f-4e63-a115-0cba3905a322,8,5
0,42,HUBS > NHS DIGITRIALS,10,19,Hospital Episode Statistics Outpatients,7,6,9,5,3,7,4,3,7ea36294-0b76-482f-b757-71f47832d67b,1,5
0,42,ALLIANCE > SAIL,10,8,Emergency Department Dataset Daily,7,6,9,1,3,7,1,0,7ed951dc-6d9f-4c08-a41c-719ec3381503,0,5
0,42,ALLIANCE > HQIP,10,29,Epilepsy 12 - National organisational audit (service descriptor questionnaire) and Trust profile,7,7,9,4,3,7,8,3,7f125091-12ba-464d-af7d-9a88179b0b95,8,5
0,42,HUBS > DISCOVER NOW,10,7,North West London Integrated Care Record (NWL ICR),7,6,9,0,3,7,1,0,7f23034b-6887-48c0-bbe7-07d099ca9395,0,5
0,42,ALLIANCE > TISSUE DIRECTORY,10,10,UK MND Collections,7,7,9,2,3,7,2,0,7f55c499-abd9-4f61-ac7e-93a4d15c79a2,0,5
0,42,ALLIANCE > HQIP,10,29,"National Audit of Dementia - spotlight audit on the prescription of psychotropic medication, 2019",7,7,9,4,3,7,8,3,7fab080b-6e2a-4c82-a5e5-daf99c70662a,8,5
0,42,ALLIANCE > TISSUE DIRECTORY,10,11,National Unified Renal Translational Research Enterprise (NURTuRE),7,7,9,2,3,7,2,0,81a515f5-5f4d-480e-b5ce-24faa7026c00,1,5
0,42,NHS Digital,10,19,Mental Health & Learning Disabilities Dataset v 1 (Sensitive) Episodes,7,6,9,5,3,7,4,3,8226b6fa-d815-4f15-9064-b56beb0fddb1,1,5
0,42,ALLIANCE > TISSUE DIRECTORY,10,11,TRICON8B,7,7,9,2,3,7,2,0,824a2ef7-d282-495e-b0fc-e25b3a9613c3,1,5
0,42,ALLIANCE > HQIP,10,29,National Audit of Dementia Round 4 - staff questionnaire,7,7,9,4,3,7,8,3,82665c1e-df7f-4136-a05f-0826533149e5,8,5
0,42,ALLIANCE > TISSUE DIRECTORY,10,11,CASPS: A Phase II trial of Cediranib in ASPS patients,7,7,9,2,3,7,2,0,82ef7d1a-98d8-48b6-9acd-461bf2a399c3,1,5
0,42,ALLIANCE > TISSUE DIRECTORY,10,10,Leeds Multidisciplinary Research Tissue Bank,7,7,9,2,3,7,2,0,8342e05e-cb12-4d29-ae84-b9b8421cb4f8,0,5
0,42,ALLIANCE > TISSUE DIRECTORY,10,11,UKALL14 Trial,7,7,9,2,3,7,2,0,843062c0-fca0-464f-aa9c-0d4908f40513,1,5
0,42,NIHR Health Informatics Collaborative Cardiovascular Theme,10,6,HIC Acute Coronary Syndromes,7,6,9,0,3,7,0,0,844f3be0-f50d-4a88-9783-0928ad1c2aad,0,5
0,42,ALLIANCE > TISSUE DIRECTORY,10,11,Epilepsy Society Brain and Tissue Bank,7,7,9,2,3,7,2,0,84616d8c-336a-485b-9148-af6788efb721,1,5
0,42,Oxford University Hospitals NHS Foundation Trust,10,33,CRIS,7,7,9,5,3,7,10,3,84de0d13-f5bd-4c22-83d3-e1adb00d5a72,9,5
0,42,ALLIANCE > CPRD,10,26,Cancer registration data for CPRD Aurum,7,6,9,5,3,7,8,3,851bb11b-fa75-44ee-afe9-948dc7652555,4,5
0,42,ALLIANCE > HQIP,10,29,National Diabetes Audit - National Diabetes in Pregnancy clinical Audit dataset,7,7,9,4,3,7,8,3,858c517e-8ce3-4059-9326-d158489e48d1,8,5
0,42,ALLIANCE > TISSUE DIRECTORY,10,8,SCOT translational sample collection,7,7,9,0,3,7,2,0,85b25afd-73a6-4455-9098-1f906bc7738d,0,5
0,42,ALLIANCE > CPRD,10,16,HES Outpatient data for CPRD GOLD,7,6,9,2,3,7,3,2,8625eb42-93df-4d33-875b-e6a93413d7ba,3,5
0,42,ALLIANCE > SAIL,10,8,Annual District Death Extract,7,6,9,1,3,7,1,0,86972216-9df3-45c3-880b-0c61647ef886,0,5
0,42,NHS Digital,10,20,HES:Civil Registration (Deaths) bridge,7,6,9,5,3,7,5,3,86d7088b-7a15-4e9a-b2b0-857a67e04650,1,5
0,42,ALLIANCE > CPRD,10,17,Death Registration data for CPRD GOLD,7,6,9,3,3,7,3,2,87244819-4596-4e5d-baaa-f3fe4eb74b4b,3,5
0,42,ALLIANCE > HQIP,10,29,National Early Inflammatory Arthritis Audit - clinical dataset,7,7,9,4,3,7,8,3,875999d5-f5ed-4136-ac20-b20f1abe27dd,8,5
0,42,ALLIANCE > NIHR BIORESOURCE,10,29,NHS Trust data,7,7,9,4,3,7,8,3,8783d7d2-2b89-44cc-bbc6-645e5483e2fe,8,5
0,42,HUBS > NHS DIGITRIALS,10,21,National Diabetes Audit,7,6,9,5,3,7,5,3,88c33d07-b009-4377-911a-8ba7bcdbf2b7,2,5
0,42,NHS Digital,10,19,Mental Health Minimum Dataset v2.6 (Non-Sensitive),7,6,9,5,3,7,4,3,895e5c2f-e484-4d08-91c6-35ac2f85c231,1,5
0,42,ALLIANCE > TISSUE DIRECTORY,10,11,Children's Cancer and Leukaemia Group (CCLG) Tissue Bank,7,7,9,2,3,7,2,0,89ae7d31-d183-4f5e-b754-7ae14449da76,1,5
0,42,ALLIANCE > CPRD,10,25,Patient postcode linked deprivation measures for CPRD Aurum,7,6,9,5,3,7,8,3,8ab1dc13-634e-46ae-9ba0-e094d446bd74,3,5
0,42,ALLIANCE > CYSTIC FIBROSIS,10,7,Sweat Tests,7,6,9,0,3,7,1,0,8b009063-5760-4915-8bcb-020ca17f8898,0,5
0,42,ALLIANCE > SAIL,10,9,Congenital Anomaly Register and Information Service,7,6,9,0,3,7,2,1,8be27887-8bf7-47bb-81c0-44900f978ab8,0,5
0,42,ALLIANCE > NHSX,10,6,The National COVID-19 Chest Imaging Database,7,6,9,0,3,7,0,0,8c13e03e-b9d2-4b04-8b98-097643a6beaf,0,5
0,42,ALLIANCE > TISSUE DIRECTORY,10,11,UNIRAD UK Sample collection,7,7,9,2,3,7,2,0,8c50b721-8bbe-4d9e-86d1-08a6271fe047,1,5
0,42,NHS Digital,10,19,Bridge file: Hospital Episode Statistics to Mental Health Minimum Data Set,7,6,9,5,3,7,4,3,8d3f80d4-aeae-46f0-809b-cd6c51e24f75,1,5
0,42,HUBS > DATA-CAN,10,8,Yorkshire Specialist Register of Cancer in Children and Young People,7,6,9,0,3,7,2,0,8e2892c2-19db-4922-85fe-60364e53f812,0,5
0,42,ALLIANCE > NIHR BIORESOURCE,10,29,Whole Genome Sequencing,7,7,9,4,3,7,8,3,8e32341b-ebad-4e10-8f2b-60b0b5b0ef4c,8,5
0,42,NHS Digital,10,20,Mental Health Services Data Set - Inpatients,7,7,9,5,3,7,5,3,8eace3c2-1dc8-4708-9350-ad129b7d2bc9,1,5
0,42,HUBS > NHS DIGITRIALS,10,21,Personal Demographic Service,7,6,9,5,3,7,5,3,907f5adc-b405-483e-ba4b-a52b7a6ead10,2,5
0,42,ALLIANCE > HQIP,10,29,National Asthma and COPD Audit Programme (NACAP): Pulmonary rehabilitation - organisational audit,7,7,9,4,3,7,8,3,91479cbf-664e-4782-8514-a3247bb5c4f4,8,5
0,42,ALLIANCE > SAIL,10,8,Welsh Demographic Service (WDS),7,6,9,0,3,7,1,1,92a4f4d2-2ba0-4c0a-9dec-f5d312d6bf8a,0,5
0,42,ALLIANCE > HQIP,10,29,National Diabetes Audit - Core Clinical Audit Dataset,7,7,9,4,3,7,8,3,92d95f82-50a5-4df9-914a-ca26b14cf84c,8,5
0,42,Oxford University Hospitals NHS Foundation Trust,10,33,Emergency Care Dataset (ECDS),7,7,9,5,3,7,10,3,93105053-ddf3-4339-9e4a-baf91c310370,9,5
0,42,ALLIANCE > SAIL,10,9,Annual District Birth Extract,7,6,9,2,3,7,0,1,9366bf21-4862-4f86-bb2d-8370b1f6dfdc,0,5
0,42,ALLIANCE > GENOMICS ENGLAND,10,6,GENOMICS ENGLAND 100K CANCER & COMMON,7,6,9,0,3,7,0,0,93ffc937-dc5f-4fae-bb75-a8ad19ac3d3e,0,5
0,42,ALLIANCE > TISSUE DIRECTORY,10,10,TwinsUK,7,7,9,2,3,7,2,0,9419a99b-f1fb-4566-8480-eecd4e189086,0,5
0,42,HUBS > INSIGHT,10,13,UHB Eye Image Dataset Release 001,7,7,9,4,3,7,3,0,94351432-da7e-4d44-97eb-4359d45e0240,0,5
2,42,NHS Digital,10,32,Secondary Uses Services,7,6,9,4,3,7,9,3,9475e59b-3fee-4775-9c18-fd5caafe7336,8,5
0,42,HUBS > BREATHE,10,6,Genetics of Asthma Severity & Phenotypes,7,7,9,0,3,7,0,0,94c082e5-b45f-43fe-9340-f4855f392fd4,0,5
0,42,ALLIANCE > TISSUE DIRECTORY,10,11,"Oncology Clinical Trials Office, University of Oxford",7,7,9,2,3,7,2,0,952d4422-3f03-46e6-9dbd-1bf0f54b7e3a,1,5
0,42,ALLIANCE > CPRD,10,25,Mental Health Dataset (MHDS) for CPRD GOLD,7,6,9,5,3,7,8,3,95475a1f-1623-4bfa-9821-1159d4dbcc8e,3,5
0,42,HUBS > BREATHE,10,9,Children's Health in London and Luton (CHILL),7,7,9,0,3,7,1,0,957329a0-6f7f-4df7-ad46-1aa4be1a507d,2,5
0,42,ALLIANCE > CPRD,10,23,Pregnancy Register for CPRD GOLD,7,6,9,5,3,7,8,3,96d29a1d-9566-4793-8dbb-351fbe2eb790,1,5
0,42,ALLIANCE > TISSUE DIRECTORY,10,11,The PEACE Study,7,7,9,2,3,7,2,0,979d600f-f541-4028-8576-a6e4603fc244,1,5
0,42,HUBS > GUT REACTION,10,30,IBD Registry,7,7,9,5,3,7,8,3,97ddd990-f47a-40f5-9178-cbf742e4c613,8,5
0,42,NHS Digital,10,19,Mental Health Minimum Dataset v4 (Sensitive) Records,7,6,9,5,3,7,4,3,97fa09e6-5ea5-41cd-baf8-20366db13a3f,1,5
0,42,ALLIANCE > SAIL,10,9,Outpatient Referral,7,6,9,0,3,7,2,1,9856fab3-1b1d-4952-abba-bcef0f92f900,0,5
0,42,ALLIANCE > TISSUE DIRECTORY,10,11,Public Health England Seroepidemiology Unit,7,7,9,2,3,7,2,0,98a03f2b-1a67-4653-a4f5-f9db7262a94d,1,5
0,42,ALLIANCE > CPRD,10,26,Quality of Life of Cancer Survivors in England: Pilot Patient Reported Outcomes Measures Survey (2011) for CPRD GOLD,7,6,9,5,3,7,8,3,992c8fe6-f460-490c-b202-8d4d9c434425,4,5
0,42,ALLIANCE > DUNDEE,10,33,Tayside Microbiology: Tests,7,7,9,5,3,7,10,3,992d45d6-c80e-474d-87ff-4503ee1210a2,9,5
0,42,HUBS > DISCOVER NOW,10,7,North West London COVID-19 Patient Level Situation Report (NWL COVID19 PLD SITREP),7,6,9,0,3,7,1,0,997a5bda-d6f2-46c7-8fe5-990ac4576ff6,0,5
0,42,ALLIANCE > HQIP,10,29,National Bowel Cancer Audit - clinical dataset,7,7,9,4,3,7,8,3,9a4ef776-6b4b-40cd-9c88-cbf1128780e9,8,5
0,42,ALLIANCE > CPRD,10,26,Cancer Patient Experience Survey (CPES) for CPRD GOLD,7,6,9,5,3,7,8,3,9a58219f-8cea-479c-bb5f-c68cae23136b,4,5
0,42,NHS Digital,10,20,Mental Health Services Data Set - Currencies,7,7,9,5,3,7,5,3,9b7f7994-0b9c-4809-b67d-45ae1f04ec5c,1,5
0,42,ALLIANCE > CPRD,10,20,HES Patient Reported Outcomes Measures (PROMs) data for CPRD GOLD,7,6,9,3,3,7,5,3,9bc66d1b-68a2-4d4e-a54a-cc3842ff95c7,3,5
0,42,ALLIANCE > HQIP,10,30,National Asthma and COPD Audit Programme (NACAP):COPD and adult asthma secondary care organisational dataset,7,7,9,5,3,7,8,3,9beca627-12cd-4231-8638-93cf0bdfa413,8,5
0,42,ALLIANCE > NIHR BIORESOURCE,10,9,Sample holding,7,6,9,0,3,7,2,0,9bfcf24b-5b13-4997-9062-6c58583e69cd,1,5
0,42,ALLIANCE > HQIP,10,29,Falls and Fragility Fracture Audit Programme National Hip Database clinical dataset,7,7,9,4,3,7,8,3,9c0f13ca-5831-4d9b-860a-7d856be7a9f1,8,5
0,42,ALLIANCE > TISSUE DIRECTORY,10,11,Tissue Access for Patient Benefit (TAPb),7,7,9,2,3,7,2,0,9cb10184-7459-4ca5-ac30-d2364e70821d,1,5
0,42,ALLIANCE > NIHR BIORESOURCE,10,29,Full Blood Counts,7,7,9,4,3,7,8,3,9ccfde56-dd13-4606-a6c1-1e797d3b8d82,8,5
0,42,ALLIANCE > TISSUE DIRECTORY,10,11,POUT-T,7,7,9,2,3,7,2,0,9e8982cb-6e2b-4c6e-b9d5-80a3794eb1dc,1,5
0,42,ALLIANCE > TISSUE DIRECTORY,10,11,MDSBio,7,7,9,2,3,7,2,0,9f45db59-b3c9-4c33-85bf-25c1b5242903,1,5
0,42,ALLIANCE > HQIP,10,29,National Early Inflammatory Arthritis Audit - patient survey,7,7,9,4,3,7,8,3,a05443cd-e292-4b5f-b1f1-95718e300d46,8,5
0,42,ALLIANCE > CPRD,10,25,Cancer registration data for CPRD GOLD,7,6,9,4,3,7,8,3,a0dad23c-c02d-4347-92ef-0019fa59eb3e,4,5
0,42,NIHR Health Informatics Collaborative Renal Transplantation Theme,10,7,HIC Transplantation,7,6,9,0,3,7,0,1,a0e0c0c2-072a-47ac-9252-e27b37ac024f,0,5
0,42,NHS Digital,10,19,Mental Health Minimum Dataset v4.1 (Non-Sensitive) Events,7,6,9,5,3,7,4,3,a1a67182-e81b-4144-ac51-92a86f277eb2,1,5
0,42,ALLIANCE > TISSUE DIRECTORY,10,11,Cam-UroOnc Biorepository,7,7,9,2,3,7,2,0,a1f9315e-8561-4e7b-b1a7-1276bdeca14d,1,5
0,42,ALLIANCE > TISSUE DIRECTORY,10,11,ICON9 Trial,7,7,9,2,3,7,2,0,a2d94442-91c1-4626-b28f-700eb436a4c1,1,5
0,42,ALLIANCE > SCOTLAND,10,16,GP Out of Hours,7,6,9,4,3,7,2,2,a33d0bb2-afe1-4f26-a8f8-7dffec7b6518,2,5
0,42,ALLIANCE > BARTS,10,33,Freetext Dataset,7,7,9,5,3,7,10,3,a429e699-4650-4feb-9392-f24aa3a3b7b6,9,5
0,42,ALLIANCE > SAIL,10,9,Bowel Screening Wales,7,6,9,0,3,7,2,1,a450ebf7-7779-48a8-8d08-892a7a650399,0,5
0,42,ALLIANCE > TISSUE DIRECTORY,10,8,Sheffield Brain Tissue Bank (SBTB),7,7,9,0,3,7,2,0,a49a1145-4334-4c2a-81cb-90155e8f05c6,0,5
0,42,HUBS > DATA-CAN,10,6,Comprehensive Patient Records for Cancer Outcomes,7,6,9,0,3,7,0,0,a5b00b37-a33e-4d8d-b0c0-045d184e05bd,0,5
0,42,ALLIANCE > TISSUE DIRECTORY,10,11,plasmaMATCH,7,7,9,2,3,7,2,0,a617a37d-1813-49ad-8282-38169981a095,1,5
0,42,ALLIANCE > BARTS,10,33,Community Services Dataset,7,7,9,5,3,7,10,3,a675ac5e-ecc2-4899-9c3c-65c2f36432c5,9,5
0,42,ALLIANCE > TISSUE DIRECTORY,10,11,UK primary Sjogren's syndrome Registry,7,7,9,2,3,7,2,0,a6fb087d-1a90-4db0-9fcf-323c5b3cce51,1,5
0,42,ALLIANCE > TISSUE DIRECTORY,10,10,Central England Haemato-oncology and oncology Research Biobank (CEHRB),7,7,9,2,3,7,2,0,a7209348-c011-44d0-9c4f-35a2014c2542,0,5
0,42,Oxford University Hospitals NHS Foundation Trust,10,33,LIMS,7,7,9,5,3,7,10,3,a74f72ad-bf70-42e4-8933-069c7b53c7f9,9,5
0,42,ALLIANCE > CPRD,10,25,Quality of Life of Colorectal Cancer Survivors in England: Patient Reported Outcome Measures Survey for CPRD Aurum,7,6,9,5,3,7,8,3,a772b8dd-cb93-4f27-a349-329992e0b212,3,5
0,42,ALLIANCE > SAIL,10,11,Breast Test Wales,7,6,9,2,3,7,2,1,a7eb2110-b105-40f8-a33a-2d9221d3c3a1,0,5
0,42,ALLIANCE > HQIP,10,29,National Asthma and COPD Audit Programme (NACAP): primary care workstream resources,7,7,9,4,3,7,8,3,a895be78-f41c-40b8-b2fa-678a071a6427,8,5
0,42,ALLIANCE > SAIL,10,8,Emergency Department Data Set,7,6,9,0,3,7,1,1,a8a6941a-080e-452a-badc-91c40841b4f3,0,5
0,42,NHS Digital,10,19,Mental Health Minimum Dataset v3_3.5 (Non-Sensitive),7,6,9,5,3,7,4,3,aa019da2-0f2f-493c-95e8-7263ee735f46,1,5
0,42,ALLIANCE > CPRD,10,17,HES Diagnostic Imaging Dataset for CPRD GOLD,7,6,9,3,3,7,3,2,aa8c53e8-f91f-41f7-9522-7e2462a9a84b,3,5
0,42,NHS Digital,10,20,Mental Health Minimum Data Set,7,6,9,5,3,7,5,3,acafb160-b18a-436e-90f1-dc4530a90267,1,5
0,42,ALLIANCE > SAIL,10,7,Substance Misuse Dataset,7,6,9,0,3,7,1,0,acc3ceeb-f4d4-47f7-996b-a7fa860e4689,0,5
0,42,ALLIANCE > TISSUE DIRECTORY,10,11,REQUITE,7,7,9,2,3,7,2,0,ace79a9e-1552-4287-9f6e-9d01f628252b,1,5
0,42,ALLIANCE > TISSUE DIRECTORY,10,10,Cardiff University Biobank,7,7,9,2,3,7,2,0,ad5c7693-983e-4f32-a979-9ab550f2084a,0,5
0,42,HUBS > BREATHE,10,19,Optimum Patient Care Research Database,7,7,9,3,3,7,3,2,ae4b8371-d037-46e8-bdcd-bf3de08ef38e,5,5
0,42,ALLIANCE > TISSUE DIRECTORY,10,11,Cambridge Blood and Stem Cell Biobank,7,7,9,2,3,7,2,0,ae4f0589-8679-48a1-ad04-2324a5001869,1,5
0,42,ALLIANCE > HQIP,10,29,National Audit of Care at the End of Life - Quality Survey,7,7,9,4,3,7,8,3,aeb2f1ea-c914-4b30-94c8-9fd3eb51b288,8,5
0,42,HUBS > DISCOVER NOW,10,7,North West London Coordinate My Care (NWL CMC),7,6,9,0,3,7,1,0,af660e81-bb96-4e85-99a8-b85147c6ba79,0,5
0,42,ALLIANCE > TISSUE DIRECTORY,10,10,RAPPER,7,7,9,2,3,7,2,0,b0886a0c-7ddc-4c2b-a499-afd7262fbe56,0,5
0,42,ALLIANCE > GENOMICS ENGLAND,10,6,GENOMICS ENGLAND 100K RARE DISEASE & COMMON,7,6,9,0,3,7,0,0,b0a8085e-8cf0-45ee-b4a6-12a4a545ca70,0,5
0,42,ALLIANCE > DUNDEE,10,33,Patient SIMD Postcode,7,7,9,5,3,7,10,3,b2124786-9658-40cc-b5a3-6624885ce490,9,5
0,42,HUBS > DISCOVER NOW,10,7,North West London Patient Index (NWL PI),7,6,9,0,3,7,1,0,b232b32f-07d4-4fce-85a0-3834efd8757a,0,5
0,42,HUBS > DISCOVER NOW,10,7,North West London Admitted Patient Care Data (NWL APC),7,6,9,0,3,7,1,0,b339ea90-c3dd-44d8-a968-88eba9e3edb3,0,5
0,42,ALLIANCE > TISSUE DIRECTORY,10,10,York Tissue Bank,7,7,9,2,3,7,2,0,b36202ad-7652-460c-8389-baa1a1c1ac46,0,5
0,42,ALLIANCE > TISSUE DIRECTORY,10,11,HCV Research UK,7,7,9,2,3,7,2,0,b3a10154-a409-491a-92fb-e7fac47ccd91,1,5
0,42,NIHR Health Informatics Collaborative Critical Care Theme,10,6,HIC ICU 8.3.2,7,6,9,0,3,7,0,0,b40777a2-468b-4b45-8b7d-2f62f912e950,0,5
0,42,ALLIANCE > BARTS,10,33,CDE Surginet Documentation,7,7,9,5,3,7,10,3,b41bb360-f2ed-49f0-a45b-b2fb05321975,9,5
0,42,ALLIANCE > CPRD,10,26,Systemic Anti-Cancer Treatment (SACT) data for CPRD Aurum,7,6,9,5,3,7,8,3,b4f6a5c2-e652-4972-9d06-510e9a469dfe,4,5
0,42,NHS Digital,10,20,Mental Health Minimum Dataset v4.1 (Non-Sensitive) Episodes,7,6,9,5,3,7,4,3,b53f716d-a5c3-4ad8-a2aa-cae09c12ac18,2,5
0,42,ALLIANCE > TISSUE DIRECTORY,10,11,MRC Brain Banks Network,7,7,9,2,3,7,2,0,b717d41e-9202-40ed-be1a-882ec0c47761,1,5
0,42,ALLIANCE > TISSUE DIRECTORY,10,11,Tissue Solutions Ltd,7,7,9,2,3,7,2,0,b730442a-72f3-4b0d-8ad3-4bdba046df7a,1,5
0,42,ALLIANCE > TISSUE DIRECTORY,10,10,TRICON8,7,7,9,2,3,7,2,0,b796b821-97cf-4aa1-bbc7-53e3c1fbc33f,0,5
0,42,ALLIANCE > DUNDEE,10,33,Tayside Radiology,7,7,9,5,3,7,10,3,b8107ec3-ba35-45ee-8231-cb610fe2ce48,9,5
0,42,ALLIANCE > DUNDEE,10,33,NHS Tayside and Fife Haematology (Lab Data Restructured),7,7,9,5,3,7,10,3,b9a2fe09-60b3-48a4-b252-9ed04a7dcc66,9,5
0,42,NHS Digital,10,19,Mental Health Minimum Dataset v4 (Non-Sensitive) Events,7,6,9,5,3,7,4,3,ba071b0b-5ef4-457b-b194-3a69c2c71a06,1,5
0,42,ALLIANCE > SAIL,10,8,Patient Episode Dataset for Wales,7,6,9,0,3,7,1,1,bb9b1a6b-e8e3-410e-85cc-61bde7a9bc7b,0,5
0,42,HUBS > DISCOVER NOW,10,7,North West London Primary Care Events Data (NWL PCE),7,6,9,0,3,7,1,0,bc2d2a17-0f36-4cb0-85d3-b54e64460d75,0,5
0,42,ALLIANCE > CPRD,10,25,Patient postcode linked deprivation measures for CPRD GOLD,7,6,9,5,3,7,8,3,bc6ae5bc-7175-49e2-b093-337dde427736,3,5
0,42,ALLIANCE > TISSUE DIRECTORY,10,11,Wales Cancer Bank,7,7,9,2,3,7,2,0,bcfdc597-1bf0-41c2-8b68-779f9a115f83,1,5
0,42,NHS Digital,10,19,Mental Health & Learning Disabilities Dataset v 1 (Sensitive) Events,7,6,9,5,3,7,4,3,bdc17b2c-8b0f-4959-ab9b-e2de32d8a5f9,1,5
0,42,ALLIANCE > CPRD,10,23,Mother-Baby Link for CPRD GOLD,7,6,9,5,3,7,8,3,bdcbbb2b-df99-4ae7-b36e-f266cfe10ed3,1,5
0,42,ALLIANCE > HQIP,10,29,National Joint Registry - Revision Shoulder Replacement dataset,7,7,9,4,3,7,8,3,bddcc89d-028f-48a5-b568-7dccd574563b,8,5
0,42,ALLIANCE > SCOTLAND,10,17,Unscheduled Care Datamart,7,6,9,4,3,7,2,2,be170751-3ab2-4cb6-a59f-d5d5867e0bfd,3,5
0,42,Oxford University Hospitals NHS Foundation Trust,10,33,TheatreEvents,7,7,9,5,3,7,10,3,bf83ada4-b72e-4789-b177-12a53aa763ea,9,5
0,42,HUBS > NHS DIGITRIALS,10,21,Civil Registration - Deaths,7,6,9,5,3,7,5,3,bfbf7741-65d1-47e3-92e2-bcf50e8c0c20,2,5
0,42,ALLIANCE > TISSUE DIRECTORY,10,10,UCL Infection DNA Bank,7,7,9,2,3,7,2,0,c10d6c3a-e405-4ee9-828f-02443c210879,0,5
0,42,HUBS > BREATHE,10,28,Vitamin D supplementation meta-analyses,7,7,9,4,3,7,8,2,c16605d7-6e6e-4461-bfab-107660e31427,8,5
0,42,ALLIANCE > TISSUE DIRECTORY,10,11,STAMPEDE,7,7,9,2,3,7,2,0,c182a3b6-8eea-43ef-be18-6cd444f150dc,1,5
0,42,HUBS > DISCOVER NOW,10,7,North West London Primary Care Prescriptions Data (NWL PCP),7,6,9,0,3,7,1,0,c1f947c3-4956-4e0b-93ef-23ce9abda000,0,5
0,42,ALLIANCE > DUNDEE,10,33,Fife Radiology,7,7,9,5,3,7,10,3,c22d8356-d51b-4d34-aadf-ed356d15fe46,9,5
0,42,ALLIANCE > DUNDEE,10,33,Tayside Bowel Screening Dataset,7,7,9,5,3,7,10,3,c275f19e-2373-43dc-8e83-3318aaf8bfa4,9,5
0,42,ALLIANCE > TISSUE DIRECTORY,10,9,Arden Tissue Bank,7,7,9,1,3,7,2,0,c29c3fbe-700e-4f85-8943-5557c30c1dfa,0,5
0,42,ALLIANCE > LEICESTER,10,28,Genvasc Primary Care Data,7,7,9,3,3,7,8,3,c324246a-22d9-45d8-9a7a-a513078be2d1,8,5
0,42,ALLIANCE > HQIP,10,29,Sentinel Stroke National Audit Programme Acute Organisational survey dataset,7,7,9,4,3,7,8,3,c3d84dfa-fe3a-4b86-a0f5-efbe45aa93ad,8,5
0,42,ALLIANCE > CPRD,10,17,HES Accident and Emergency data for CPRD GOLD,7,6,9,2,3,7,4,2,c55b92d8-889d-435c-b0cb-2d9f7b432839,3,5
0,42,ALLIANCE > CPRD,10,17,Death Registration data for CPRD Aurum,7,6,9,3,3,7,3,2,c577669a-a84f-493e-8164-3fe02f618561,3,5
0,42,ALLIANCE > HQIP,10,29,National Audit of Psychosis - Audit on Early Intervention in Psychosis services - contextual data,7,7,9,4,3,7,8,3,c5994fae-9c4a-47eb-ba42-85bd76e92879,8,5
0,42,ALLIANCE > CPRD,10,25,Practice postcode linked deprivation measures for CPRD GOLD,7,6,9,5,3,7,8,3,c6117afd-bc4d-404b-8d58-9d87db936b4c,3,5
0,42,ALLIANCE > TISSUE DIRECTORY,10,11,Barts CTU,7,7,9,2,3,7,2,0,c6d6bbd3-74ed-46af-841d-ac5e05f4da41,1,5
0,42,OTHER > COG-UK,10,6,COG-UK Viral Genome Sequences,7,6,9,0,3,7,0,0,c6dc78fa-1543-4fbf-87d8-a3f48e7de813,0,5
0,42,NHS Digital,10,19,Mental Health & Learning Disabilities Dataset v 1 (Non-Sensitive) Episodes,7,6,9,5,3,7,4,3,c713773c-e961-400e-b44a-947002deb073,1,5
0,42,ALLIANCE > CYSTIC FIBROSIS,10,8,NTM culture,7,6,9,1,3,7,1,0,c7db2002-4fbd-4c46-8032-e53a73e08c16,0,5
0,42,ALLIANCE > TISSUE DIRECTORY,10,9,RATHL Trial,7,7,9,0,3,7,2,0,c83d2206-3778-400b-9b26-27c7588af930,1,5
0,42,ALLIANCE > DUNDEE,10,33,NHS Tayside and Fife Virology,7,7,9,5,3,7,10,3,c8ed8784-91ce-4823-8e80-fa3a4b732e11,9,5
0,42,NHS Digital,10,19,Mental Health Minimum Dataset v4.1 (Non-Sensitive) Records,7,6,9,5,3,7,4,3,c97b8058-a6a4-4c8d-92e1-6e9f4cddd301,1,5
0,42,ALLIANCE > HQIP,10,29,National Audit of Care at the End of Life - case note review,7,7,9,4,3,7,8,3,cabb1db1-ee3e-42ce-a40b-468282e2011d,8,5
0,42,University of Bristol,10,10,Avon Longitudinal Study of Parents and Children,7,7,9,0,3,7,2,1,cacfd200-8c88-433d-9693-9917d778880b,1,5
0,42,ALLIANCE > HQIP,10,29,National Early Inflammatory Arthritis Audit - organisational survey dataset,7,7,9,4,3,7,8,3,cbda5643-96b7-4914-b990-a872e693ff29,8,5
0,42,NHS Digital,10,19,Mental Health Minimum Dataset v4.1 (Sensitive) Records,7,6,9,5,3,7,4,3,cc383a3f-1c47-4b7d-99cf-be8ee0afe401,1,5
0,42,ALLIANCE > CPRD,10,16,HES Admitted Patient Care data for CPRD Aurum,7,6,9,2,3,7,3,2,cc3e20da-aca5-471d-a4bb-38e13f350f10,3,5
0,42,ALLIANCE > SCOTLAND,10,16,National Records of Scotland (NRS) - Births Data,7,7,9,4,3,7,2,1,cd051ddc-b383-4583-aeca-b2e1fe5b17e3,3,5
0,42,ALLIANCE > PUBLIC HEALTH ENGLAND,10,9,National Cancer Registration Dataset 2018,7,7,9,1,3,7,0,1,cd0cc1de-f0bc-4247-9e67-47e162e2cc6b,1,5
0,42,ALLIANCE > SCOTLAND,10,17,Child Health Systems Programme - 4-5 year review,7,6,9,4,3,7,2,2,ce9025c9-cf30-420b-8edb-f6ca438b099f,3,5
0,42,ALLIANCE > SCOTLAND,10,17,Child Health Systems Programme - 27-30Months Review,7,6,9,4,3,7,2,2,ceca959a-11b1-4da3-8289-3cf22c9fc541,3,5
0,42,ALLIANCE > HQIP,10,29,National Clinical Audit of Anxiety and Depression - spotlight audit on psychological therapies (clinical),7,7,9,4,3,7,8,3,cf3f4336-e52d-4b82-8cc5-647dedaaee57,8,5
0,42,ALLIANCE > CPRD,10,25,Quality of Life of Colorectal Cancer Survivors in England: Patient Reported Outcome Measures Survey for CPRD GOLD,7,6,9,5,3,7,8,3,cf81a42f-2611-4410-89e9-7e3770d03a15,3,5
0,42,ALLIANCE > TISSUE DIRECTORY,10,11,Cancer Group CTR Cardiff trials,7,7,9,2,3,7,2,0,d272b783-8db3-4068-8d0f-05728f786d6d,1,5
2,42,NHS Digital,10,32,Patient Reported Outcome Measures,7,6,9,4,3,7,9,3,d2af6a29-291b-4444-a17c-40f4208f1e1b,8,5
0,42,ALLIANCE > HQIP,10,29,Sentinel Stroke National Audit Programme Clinical Dataset,7,7,9,4,3,7,8,3,d3673b75-ec8f-4c2e-8c9b-6ef1d951f978,8,5
0,42,ALLIANCE > TISSUE DIRECTORY,10,10,MFT Biobank,7,7,9,2,3,7,2,0,d3a3935f-b28e-4e74-9b15-9432d611f26c,0,5
0,42,Oxford University Hospitals NHS Foundation Trust,10,33,JANUS,7,7,9,5,3,7,10,3,d3fd4dac-2d15-401c-8185-905ee108d9ce,9,5
0,42,ALLIANCE > TISSUE DIRECTORY,10,10,UK ME/CFS Biobank,7,7,9,2,3,7,2,0,d51de39c-153a-462b-8de5-cd1424908e0c,0,5
0,42,HUBS > PIONEER,10,29,Birmingham Out of Hours Research Database,7,7,9,4,3,7,8,3,d546521a-79be-4a53-83bd-ff008bda6171,8,5
0,42,Oxford University Hospitals NHS Foundation Trust,10,33,OUH Patient Master Index,7,7,9,5,3,7,10,3,d57a096a-4fa3-4529-b508-0b9df0f1893c,9,5
0,42,ALLIANCE > TISSUE DIRECTORY,10,10,NHS Grampian Biorepository,7,7,9,2,3,7,2,0,d5ab658e-b474-4e22-95f8-92607c40792d,0,5
0,42,ALLIANCE > SAIL,10,8,Maternity Indicators Dataset,7,6,9,0,3,7,1,1,d7c1b02d-0e41-4244-98f3-6250519b4c79,0,5
0,42,ALLIANCE > NIHR BIORESOURCE,10,9,Health and Lifestyle Questionnaire,7,6,9,0,3,7,2,0,d7ec9584-cba3-46f9-9ef4-b1cb9eef2e7c,1,5
0,42,ALLIANCE > CPRD,10,26,Cancer Patient Experience Survey (CPES) for CPRD Aurum,7,7,9,5,3,7,8,3,d90830f4-5aaa-4075-8c8d-839627224d16,4,5
0,42,ALLIANCE > SCOTLAND,10,14,Outpatient Appointments and Attendances - Scottish Morbidity Record (SMR00),7,7,9,1,3,7,2,2,d936d21f-6b78-470c-b623-6d1213f2a041,3,5
0,42,ALLIANCE > HQIP,10,29,National Vascular Registry -  Abdominal Aortic Aneurysm Repair clinical dataset,7,7,9,4,3,7,8,3,da4d3e21-3d81-49e9-ada0-6175e2341190,8,5
0,42,NHS Digital,10,19,Mental Health Minimum Dataset v4.1 (Sensitive) Events,7,6,9,5,3,7,4,3,db113fcd-69a0-4357-9c6d-250085deb3f5,1,5
0,42,ALLIANCE > TISSUE DIRECTORY,10,11,interNational Anaplastic Thyroid Cancer Tissue Bank (iNATT),7,7,9,2,3,7,2,0,dd7e56e7-2683-4b88-bed2-3a27ef3e4c9e,1,5
0,42,ALLIANCE > HQIP,10,29,National Vascular Registry Audit Carotid Endarterectomy Clinical Dataset,7,7,9,4,3,7,8,3,ddc965e7-6f52-4eed-bed5-657e3e7bbeac,8,5
0,42,ALLIANCE > NIHR BIORESOURCE,10,31,NHS Digital data,7,7,9,4,3,7,9,3,de1179eb-89fe-45a3-9e3c-e54a2a36ebf0,9,5
0,42,ALLIANCE > HQIP,10,29,National Bowel Cancer Audit -  Organisational Survey dataset,7,7,9,4,3,7,8,3,de19b3ea-2600-4472-85e8-628e7beff76e,8,5
0,42,HUBS > BREATHE,10,6,UK Lung Volume Reduction Surgery,7,7,9,0,3,7,0,0,def6669b-0fac-485c-84b2-2ea83ec31123,0,5
0,42,ALLIANCE > SCOTLAND,10,16,National Records of Scotland (NRS) - Deaths Data,7,7,9,4,3,7,2,1,df63bdd2-712d-478e-8aae-36d01158a440,3,5
0,42,Oxford University Hospitals NHS Foundation Trust,10,33,Admitted Patient Care Dataset,7,7,9,5,3,7,10,3,dfb21b3b-7fd9-40c4-892e-810edd6dfc25,9,5
0,42,ALLIANCE > GENOMICS ENGLAND,10,6,GENOMICS ENGLAND 100K PHE LINKED DATA,7,6,9,0,3,7,0,0,e0c871f9-b63c-43a5-9fd6-e5731dae2343,0,5
0,42,ALLIANCE > SAIL,10,6,Brecon dataset,7,6,9,0,3,7,0,0,e0ed59e2-8fb5-44d4-b694-f31d46884954,0,5
0,42,ALLIANCE > HQIP,10,29,National Oesophago-Gastric Cancer Audit - clinical dataset,7,7,9,4,3,7,8,3,e10660af-b420-4e25-8fc9-ea451da1dcfb,8,5
0,42,ALLIANCE > HQIP,10,29,National Joint Registry - Primary Ankle Replacement dataset,7,7,9,4,3,7,8,3,e38c8d6c-8655-4432-b654-23f89c0bb495,8,5
0,42,ALLIANCE > CYSTIC FIBROSIS,10,8,Chronic Medication,7,6,9,1,3,7,1,0,e3c2d5ff-e08b-4fc9-a874-19123fab7183,0,5
0,42,HUBS > BREATHE,10,28,Unified Cohorts Research Network,7,7,9,4,3,7,8,2,e516a359-74a8-4932-b4df-f2cf75eef89d,8,5
0,42,ALLIANCE > TISSUE DIRECTORY,10,11,Biobank for patients with retinal degenerations & dystrophies,7,7,9,2,3,7,2,0,e678366e-bb53-4dbb-a228-05114e0b6eb3,1,5
0,42,HUBS > DISCOVER NOW,10,7,North West London Community Data (NWL COM),7,6,9,0,3,7,1,0,e85e5c8c-b6be-4e8b-8a0b-13b785b457a2,0,5
0,42,ALLIANCE > TISSUE DIRECTORY,10,11,University of Liverpool - GCP Laboratory Facility,7,7,9,2,3,7,2,0,e8f23004-f1f7-4a36-859f-25af6ca6433b,1,5
0,42,ALLIANCE > DUNDEE,10,33,"NHS Tayside, A&E Drugs given during an A&E visit",7,7,9,5,3,7,10,3,e8f5b1b5-2c08-439a-b337-70b454aa40f3,9,5
0,42,"HUBS > GUT REACTION, ALLIANCE > NIHR BIORESOURCE",10,8,Demographic,7,6,9,0,3,7,1,0,e9b1ef97-ff63-4336-b3f8-2d5c5f5accce,1,5
0,42,ALLIANCE > TISSUE DIRECTORY,10,8,Research Donors Ltd,7,7,9,0,3,7,2,0,ea07f115-9f70-4c21-a373-247a1ca906f0,0,5
0,42,Oxford University Hospitals NHS Foundation Trust,10,33,Sunquest,7,7,9,5,3,7,10,3,eaca9ed1-30b6-4157-8894-8e53efc84849,9,5
0,42,ALLIANCE > TISSUE DIRECTORY,10,10,Tommy's National Reproductive Health Biobank,7,7,9,2,3,7,2,0,eb19fcd9-2e9e-4e27-aa79-ad235952b1ac,0,5
0,42,HUBS > NHS DIGITRIALS,10,19,Diagnostic Imaging Dataset,7,6,9,5,3,7,4,3,eb80104c-1292-49b7-9d18-58337353c4cc,1,5
0,42,ALLIANCE > GENOMICS ENGLAND,10,6,GENOMICS ENGLAND 100K QUICK VIEW,7,6,9,0,3,7,0,0,ecbe7275-82b5-43cd-9401-fd7ef4b55341,0,5
0,42,ALLIANCE > DUNDEE,10,33,Fife Microbiology: Isolations,7,7,9,5,3,7,10,3,edaf29f4-9857-4bb0-97b9-ae88b70a2a3c,9,5
0,42,HUBS > BREATHE,10,7,Its Not JUST Idiopathic pulmonary fibrosis Study (INJUSTIS),7,7,9,0,3,7,1,0,edc8f0c6-64f8-4f6d-a1dd-41e05033d54e,0,5
0,42,ALLIANCE > TISSUE DIRECTORY,10,10,QTL Programme at MRC HGU,7,7,9,2,3,7,2,0,ee5f4405-6930-4a7b-ba00-85a8e8c8a8b9,0,5
0,42,ALLIANCE > SAIL,10,6,National Survey for Wales,7,6,9,0,3,7,0,0,ee78ce42-7f1f-4c97-80cc-ea6ad628e5da,0,5
0,42,ALLIANCE > TISSUE DIRECTORY,10,10,Manchester Cancer Research Centre (MCRC) Biobank,7,7,9,2,3,7,2,0,eea147a4-4576-4f86-8ad1-c762137335fd,0,5
0,42,ALLIANCE > CPRD,10,11,CPRD Aurum,7,6,9,1,3,7,2,1,ef42201e-deb1-4675-896a-8a0162fe52a8,1,5
0,42,ALLIANCE > HQIP,10,29,National Cardiac Audit Programme - National Heart Failure Audit,7,7,9,4,3,7,8,3,efbb3bf4-834b-417e-b002-03fc41715e58,8,5
0,42,HUBS > PIONEER,10,29,Society for Acute Medicine Benchmarking Audit,7,7,9,4,3,7,8,3,f075ceb7-5bed-4e6b-8e83-211aee945356,8,5
0,42,ALLIANCE > NIHR BIORESOURCE,10,30,SNP imputation data,7,7,9,5,3,7,8,3,f1a85970-bddc-499b-92e9-783706c60995,8,5
0,42,ALLIANCE > TISSUE DIRECTORY,10,11,Manchester Eye Tissue Repository,7,7,9,2,3,7,2,0,f1a93b8f-6332-43a2-b2da-c86f68f7d24a,1,5
0,42,ALLIANCE > NIHR BIORESOURCE,10,9,Case report form,7,6,9,0,3,7,2,0,f1d3b068-7dd0-4a28-bd64-3519dd104eb6,1,5
0,42,ALLIANCE > CPRD,10,25,Practice postcode linked deprivation measures for CPRD Aurum,7,6,9,5,3,7,8,3,f3a53f7a-ea93-4b9e-bccd-afe762259044,3,5
0,42,ALLIANCE > LEICESTER,10,29,The Leicester City and County Chronic Kidney Disease Cohort,7,7,9,4,3,7,8,3,f3ade619-292e-4631-916a-9cd9d7938e48,8,5
0,42,ALLIANCE > TISSUE DIRECTORY,10,11,Bristol Biobank,7,7,9,2,3,7,2,0,f42b9fa6-adad-4637-943e-6fa7508559a3,1,5
0,42,ALLIANCE > HQIP,10,10,National Joint Registry - Primary Knee Replacement dataset,7,7,9,0,3,7,2,1,f4915e4b-639c-45ae-9b0f-afab547e1104,1,5
0,42,ALLIANCE > TISSUE DIRECTORY,10,11,Leeds NIHR Biomarker Research Tissue Bank,7,7,9,2,3,7,2,0,f5b57b56-a4ed-46d4-825f-d181e8db809d,1,5
0,42,ALLIANCE > TISSUE DIRECTORY,10,11,Oxford Musculoskeletal Biobank,7,7,9,2,3,7,2,0,f5ed34fa-154a-4613-a253-277547cfd8ca,1,5
0,42,ALLIANCE > TISSUE DIRECTORY,10,11,NIHR Exeter Clinical Research Facility,7,7,9,2,3,7,2,0,f621fcc9-e9ab-4da4-bd34-e4530d11b59d,1,5
0,42,ALLIANCE > HQIP,10,29,National Diabetes Inpatient Audit - Harms clinical dataset,7,7,9,4,3,7,8,3,f69d1b15-a0b4-461a-8aff-dba56da0791f,8,5
0,42,ALLIANCE > SAIL,10,10,Diagnostic and Therapy Services Waiting Times,7,6,9,0,3,7,2,2,f709c58e-ae5b-440b-8db1-d39caf160b17,0,5
0,42,ALLIANCE > TISSUE DIRECTORY,10,11,Generation Scotland,7,7,9,2,3,7,2,0,f72798fb-d168-4c3c-abce-f8300cbcb8b3,1,5
0,42,ALLIANCE > SCOTLAND,10,15,Scottish Cancer Registry (SMR06),7,7,9,2,3,7,2,2,f79d91c1-981e-4389-8626-b2cef391cf90,3,5
0,42,ALLIANCE > NIHR BIORESOURCE,10,11,SNP chip data,7,6,9,2,3,7,2,0,f7c563c0-9625-47be-a070-c121fe734f3c,1,5
0,42,ALLIANCE > HQIP,10,29,National Maternity and Perinatal Audit clinical audit,7,7,9,4,3,7,8,3,f806fe65-79aa-4843-bc56-a08bf14ffcec,8,5
0,42,ALLIANCE > HQIP,10,29,"Maternal, Newborn and Infant Clinical Outcome Review Programme - perinatal surveillance dataset",7,7,9,4,3,7,8,3,f82b8ca5-5a52-4502-bf78-cfbb718cbe2f,8,5
0,42,ALLIANCE > BARTS,10,33,Maternity Services Dataset,7,7,9,5,3,7,10,3,f8bab14a-bc9b-4dd1-a6c6-c57588605849,9,5
0,42,ALLIANCE > TISSUE DIRECTORY,10,11,Multiple Sclerosis and Parkinson's Tissue Bank,7,7,9,2,3,7,2,0,f8f6e9ea-65c0-48a6-9beb-6de80bbbefda,1,5
0,42,HUBS > BREATHE,10,8,SpiroMeta Consortium Dataset,7,7,9,0,3,7,0,0,f908efd6-c6ac-448b-89b9-222c50aec7c8,2,5
0,42,ALLIANCE > TISSUE DIRECTORY,10,10,UCL / UCLH Biobank for Studying Health and Disease,7,7,9,2,3,7,2,0,f9a712ae-9d41-41a6-b2ca-3127441b03ac,0,5
0,42,ALLIANCE > TISSUE DIRECTORY,10,10,"St Thomas' Hospitals Plasma, serum & DNA Bio bank from patients with antiphospholipid antibodies",7,7,9,2,3,7,2,0,f9f3af0d-ca1c-4e8f-b5e8-20962e1e7b4e,0,5
0,42,ALLIANCE > HQIP,10,29,National Cardiac Audit Programme - National Adult Cardiac Surgery Audit (NACSA),7,7,9,4,3,7,8,3,faf7ec31-999a-4d87-9d6d-8837ff2fa486,8,5
0,42,Oxford University Hospitals NHS Foundation Trust,10,33,CellPath,7,7,9,5,3,7,10,3,fc7b44f0-eb69-4257-8c07-7516c1210c46,9,5
0,42,ALLIANCE > TISSUE DIRECTORY,10,10,eLIXIR - Early Life Data Cross-Linkage in Research,7,7,9,2,3,7,2,0,fcee6c99-a4bd-44b8-a28e-dc63337ce216,0,5
0,42,ALLIANCE > SAIL,10,8,Referral to Treatment Times,7,6,9,0,3,7,1,1,fd8c878e-c497-4ec2-bc67-ecb347613384,0,5
0,42,ALLIANCE > SAIL,10,6,National Exercise Referral Scheme,7,6,9,0,3,7,0,0,fe3c7527-e802-4a51-9aa2-19e7d4d22783,0,5
0,42,ALLIANCE > HQIP,10,29,National Joint Registry - Primary Shoulder Replacement dataset,7,7,9,4,3,7,8,3,fe4662ad-9080-4bd8-8de4-51195d275d5b,8,5
0,42,ALLIANCE > HQIP,10,29,National Paediatric Diabetes Audit - Parent and Patient Recorded Experience measures,7,7,9,4,3,7,8,3,fe872375-2401-4de1-9650-d4139cf5793a,8,5
0,42,HUBS > BREATHE,10,6,Wales Asthma Observatory,7,7,9,0,3,7,0,0,fe9bf0d9-3212-4120-96a6-d455f92dd192,0,5
0,42,NHS Digital,10,19,Mental Health Minimum Dataset v4 (Non-Sensitive) Records,7,6,9,5,3,7,4,3,ff2c6982-00f3-4483-9fc2-19b3a7211d8d,1,5
